MAGGIE CHEN: Open Payments
NPI 1487316030 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,590 in 125 payments from 30 companies in 2025. Trend: 2023 $1,129 · 2024 $2,731 · 2025 $2,590
Food & beverage: $2,590
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $314 |
| Otsuka America Pharmaceutical, Inc. | 10 | $263 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $227 |
| Corcept Therapeutics | 8 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $142 |
| ABBVIE INC. | 7 | $138 |
| Lilly USA, LLC | 9 | $136 |
| ABIOMED | 1 | $120 |
| Sumitomo Pharma America, Inc. | 6 | $112 |
| Novo Nordisk Inc | 6 | $102 |
Products named: CAPLYTA, JYNARQUE, Korlym, REXULTI, Kerendia, BREZTRI, AIRSUPRA, JARDIANCE.
Industry payments across FL — which companies pay providers there.
